Recent Quotes

"We believe STEM represents an interesting investment story."

— Edward Woo, Ascendiant Capital Markets (8/7/15)
more >

"We expect 2015 to have significant clinical milestones for STEM."

— Edward Woo, Ascendiant Capital Markets (6/30/15)
more >

"NBY's Avenova has a $600M market potential, which presents a high reward for the risks."

— Edward Woo, Ascendiant Capital Markets (5/20/15)
more >

"NBY is making good progress with Avenova, with sales doubling from January to February."

— Edward Woo, Ascendiant Capital Markets (3/27/15)
more >



Due to permission requirements, not all quotes are shown.